Get the Stockscreener App
0.8882
4.59%
0.039
Oncology Institute Inc Stock (TOI) Latest News
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying - Yahoo Finance
Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle
Oncology Institute Inc [TOI] Stock bought by Insider Hively Brad for $42500.0 - Knox Daily
The Oncology Institute Inc (TOI) had a good session last reading, didn’t it? - US Post News
Why The Oncology Institute (TOI) Is Skyrocketing So Far In 2025 - Insider Monkey
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Large Growth in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company - Simply Wall St
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire
The Oncology Institute Inc WT (TOIIW-Q) QuotePress Release - The Globe and Mail
HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute faces potential Nasdaq delisting - Investing.com
Florida Blue enhances cancer care for thousands of members - The Manila Times
Florida Blue Launches Breakthrough Cancer Care Program with The Oncology Institute Partnership - StockTitan
Brian Druker resigns as OHSU Knight Cancer Institute CEO - The Business Journals
Oncology institute director Brad Hively acquires $50,000 in stock - Investing.com
Oncology institute director Brad Hively acquires $50,000 in stock By Investing.com - Investing.com UK
Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St
Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
RenovoRx Expands Phase III Pancreatic Cancer Trial with Major Cancer Institute Partnership - StockTitan
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
USF and TGH partner with robotics company to become the first to bring life-saving surgical technology to Tampa Bay - University of South Florida
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Oncology Institute Reports Third Quarter 2024 Financial Results - The Manila Times
Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan
Oncology Institute Announces Board Changes for 2025 - TipRanks
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times
Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
Cancer Care - WellSpan Health
Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com
GlycoMimetics, Inc. Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Marketscreener.com
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute - RWJBarnabas Health
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
5.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):